STOCK TITAN

MapLight Therapeutics officer proposes $132K share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144/A

Rhea-AI Filing Summary

MapLight Therapeutics, Inc. officer Lillie James Woodruff reported 4,896 common shares for sale, with an aggregate market value of $132,289.92; the approximate sale date is April 15, 2026. The shares are to be sold solely to satisfy tax-withholding obligations in connection with restricted stock unit (RSU) vesting.

Common shares reported for sale 4,896 shares Approximate sale date: April 15, 2026
Aggregate market value $132,289.92 Common shares reported for sale
Shares outstanding 42,440,000 shares Securities information
Restricted stock unit grant 3,200 shares Dated July 30, 2023
Restricted stock unit grant 1,434 shares Dated November 9, 2023
Restricted stock unit grant 6,147 shares Dated May 2, 2024
Restricted Stock Unit Grant financial
"Nature of Acquisition Transaction: Restricted Stock Unit Grant"
RSU vesting financial
"in connection w/ RSU vesting"
RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.
tax-withholding obligations financial
"solely to satisfy tax-withholding obligations"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MPLT shares did Lillie James Woodruff report for sale?

Lillie James Woodruff, an officer of MapLight Therapeutics, reported 4,896 common shares for sale, with an aggregate market value of $132,289.92. The approximate sale date is April 15, 2026.

What RSU grants are listed in the MPLT notice?

The listed restricted stock unit grants are 3,200 shares dated July 30, 2023, 1,434 shares dated November 9, 2023, and 6,147 shares dated May 2, 2024.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144/A: Filer Information

144/A: Issuer Information

144/A: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

144/A: Remarks and Signature

Keep reading